Source: https://www.usherbrooke.ca/dep-medecine/recherche/professeurs-ayant-des-activites-de-recherche/rhumatologie/pr-gilles-boire/
Timestamp: 2019-04-19 12:42:18+00:00

Document:
Pr Gilles Boire, M.D., M. Sc.
Membre de l'axe de recherche et du thème porteur "Inflammation-douleur" du CRC-Étienne LeBel du CHUS et de la Faculté de médecine et des sciences de la santé de l'Université de Sherbrooke.
Antigénicité et fonction des petits ARN non codants hY.
Biomarqueurs et déterminants psychosociaux dans les issues cliniques dans la polyarthrite inflammatoire d'installation récente.
Prévention secondaire des fractures de fragilité osseuse.
Early prediction of patient-related and radiological outcomes in patients with recent-onset inflammatory polyarthritis (EPA) using established and novel independent predictors.
Co-chercheurs : Cossette P, Daniel C, de Brum-Fernandes A, Dobkin PL, Kurgan L, Ménard HA, Arsenault G, Liang P, Bruns A.
Partnership for applied research in fracture prevention programs for the elderly.
Co-chercheurs : Beaulieu M-C, Cabana F, Boire G, et al.
Developing Advanced Methods for Population-Based Comparative Effectiveness Studies.
Co-chercheurs : Boire G, et al.
Empowering Patients as Active Partners in Their Care: Lupus Interactive Navigator (LIN).
The role of Y RNA-related sequences in shaping genomes.
Liens entre l'exercice, l'activité et la physiopathologie chez les enfants atteints d'arthrite juvénile.
Étude in vitro de l'effet des immunoglobulines pour injection intraveineuse (IVIg) sur les lymphocytes B de patients atteints de lupus érythémateux disséminé.
Co-chercheurs : Liang P, Roux S, et al.
Longueur des télomères des cellules du sang périphérique de patients avec arthrite inflammatoire débutante.
Ostéoporose et fractures périphériques : traitement et investigation multidisciplinaire au CHUS (OPTIMUS).
Merck Frosst Canada et Alliance Aventis / Proctor & Gamble / Novartis Pharma Canada / Servier Canada / Amgen Canada.
Validation prospective de biomarqueurs solubles comme prédicteurs de dommages structuraux dans la polyarthrite rhumatoïde.
Titre de la recherche : Évaluation de l'impact du nombre de cercles d'excision thymiques (TREC) et du raccourcissement des télomères sur les issues clliniques de la polyarthrite inflammatoire débutante.
Titre de la recherche : Echographic characterization of the lateral hip pain syndrome.
Titre de la recherche : Role of echography to assess risk of recurrence on drug withdrawal in RA patients in remission.
Titre de la recherche : Osteoclast apoptosis.
Titre de la recherche : Y RNAs as microRNAs.
Titre de la recherche : Marqueurs pronostiques dans la polyarthrite débutante.
Titre de la recherche : The role of Y RNA sequences in shaping genomes.
Titre de la recherche : Use of allopurinol start during an acute gouty attack.
Titre de la recherche : Allopurinol use in acute gouty attacks.
Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
Choy T, Bykerk VP, Boire G, Haraoui BP, Hitchon C, Thorne C, Keystone EC, Pope JE; on behalf of CATCH Investigators.
Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the canadian early arthritis cohort.
Harris JA, Bykerk VP, Hitchon CA, Keystone EC, Thorne JC, Boire G, Haraoui B, Hazlewood G, Bonner AJ, Pope JE; CATCH Investigators.
Factors associated with time to diagnosis in early rheumatoid arthritis.
Barnabe C, Xiong J, Pope JE, Boire G, Hitchon C, Haraoui B, Carter Thorne J, Tin D, Keystone EC, Bykerk VP; Canadian early ArThritis CoHort (CATCH) Study Investigators.
The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Results from the CATCH Cohort.
Boyd TA, Bonner A, Thorne C, Boire G, Hitchon C, Haraoui BP, Keystone EC, Bykerk VP, Pope JE.
Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.
Bissonnette L, April PM, Dumais R, Boire G, Roux S.
Therapies for active rheumatoid arthritis after methotrexate failure.
O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E; CSP 551 RACAT Investigators (Boire G).
Prevention of rheumatoid arthritis: the very first steps.
Masetto A, Beaulieu MC, Boire G.
Shah M, Targoff IN, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group (Boire G).
Yougbaré I, Boire G, Roy M, Lugnier C, Rouseau E.
Priming primary care physicians to treat osteoporosis after a fragility fracture: an integrated multidisciplinary approach.
Roux S, Beaulieu M, Beaulieu MC, Cabana F, Boire G.
Anticitrullinated Protein Antibodies and Rheumatoid Factor Fluctuate in Early Inflammatory Arthritis and Do Not Predict Clinical Outcomes.
Barra L, Bykerk V, Pope JE, Haraoui BP, Hitchon CA, Thorne JC, Keystone EC, Boire G; , and the CATCH Investigators.
Partnership for fragility bone fracture care provision and prevention program (P4Bones): study protocol for a secondary fracture prevention pragmatic controlled trial.
Gaboury I, Corriveau H, Boire G, Cabana F, Beaulieu MC, Dagenais P, Gosselin S, Bogoch E, Rochette M, Filiatrault J, Laforest S, Jean S, Fansi A, Theriault D, Burnand B.
Predictors of pain for patients with early inflammatory polyarthritis.
Dobkin PL, Liu A, Abrahamowicz M, Carrier N, de Brum-Fernandes AJ, Cossette P, Boire G.
Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro osteoclast differentiation in arthritis (IODA) study.
Durand M, Komarova SV, Bhargava A, Li K, Fiorino C, Maria O, Nabavi N, Manolson MF, Harrison RE, Jeffrey Dixon S, Sims SM, Mizianty MJ, Kurgan L, Haroun S, Boire G, de Fatima Lucena-Fernandes M, Brum-Fernandes AJ.
Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG;Childhood Myositis Heterogeneity Collaborative Study Group (Boire G).
Medicine (Baltimore). 2013 Jan;92(1):25-41. doi: 10.1097/MD.0b013e31827f264d.
Increasing Treatment in Early Rheumatoid Arthritis Is Not Determined by the Disease Activity Score But by Physician Global Assessment: Results from the CATCH Study.
Pyne L, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC, Keystone EC, Pope JE; for the CATCH Investigators.
Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort.
Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, Blocka KL, Bell MJ, Lacaille D, Hitchon CA, Fitzgerald AA, Fidler WK, Bookman AA, Henderson JM, Mosher DP, Sholter DE, Khraishi M, Haraoui B, Chen H, Li X, Laupacis A, Boire G, Tomlinson G, Bombardier C.
Bykerk VP, Jamal S, Boire G, Hitchon CA, Haraoui B, Pope JE, Thorne JC, Sun Y, Keystone EC.
Incidence and predictors of secondary fibromyalgia in an early arthritis cohort.
Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE, Thorne JC, Keystone EC, Solomon DH, Bykerk VP.
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA, Boire G, Haraoui B, Ferland DS, Keystone EC, Pope JE; on behalf of the CATCH Investigators.
Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria.
Kuriya B, Sun Y, Boire G, Haraoui B, Hitchon C, Pope JE, Thorne JC, Keystone EC, Bykerk VP; Canadian Early Arthritis Cohort Study.
Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohort.
Mussen L, Boyd T, Bykerk V, de Leon F, Li L, Boire G, Hitchon C, Haraoui B, Thorne JC, Pope J.
Safety and effectiveness of rituximab in patients with rheumatoid arthritis following an inadequate response to 1 prior tumor necrosis factor inhibitor: the RESET Trial.
Haraoui B, Bokarewa M, Kallmeyer I, Bykerk VP; RESET Investigators (Boire G).
Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a National, Multicenter, Retrospective cohort.
A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles.
Budarf ML, Goyette P, Boucher G, Lian J, Graham RR, Claudio JO, Hudson T, Gladman D, Clarke AE, Pope JE, Peschken C, Smith CD, Hanly J, Rich E, Boire G, Barr SG, Zummer M; GenES Investigators, Fortin PR, Wither J, Rioux JD.
The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - The In Vitro Osteoclast Differentiation in Arthritis (IODA) study.
Durand M, Boire G, Komarova SV, Dixon SJ, Sims SM, Harrison RE, Nabavi N, Maria O, Manolson MF, Mizianty M, Kurgan L, de Brum-Fernandes AJ.
Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®).
Cheng CK, McDonald-Blumer H, Boire G, Pope JE, Haraoui B, Hitchon CA, Thorne C, Sun Y, Bykerk VP.
Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents.
Cooper GS, Wither J, Bernatsky S, Claudio JO, Clarke A, Rioux JD; CaNIOS GenES Investigators, Fortin PR.
Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies.
Guzian MC, Carrier N, Cossette P, de Brum-Fernandes AJ, Liang P, Ménard HA, Boire G.
Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis.
Katchamart W, Bourré-Tessier J, Donka T, Drouin J, Rohekar G, Bykerk VP, Haraoui B, Leclerq S, Mosher DP, Pope JE, Shojania K, Thomson J, Thorne JC, Bombardier C; Canadian 3e Initiative Consensus Group.
Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.
Oen K, Duffy CM, Tse SM, Ramsey S, Ellsworth J, Chédeville G, Chetaille AL, Saint-Cyr C, Cabral DA, Spiegel LR, Schneider R, Lang B, Huber AM, Dancey P, Silverman E, Rosenberg AM, Cameron B, Johnson N, Dorval J, Scuccimarri R, Campillo S, Petty RE, Duffy KN, Boire G, Haddad E, Houghton K, Laxer R, Turvey SE, Miettunen P, Gross K, Guzman J, Benseler S, Feldman BM, Espinosa V, Yeung RS, Tucker L.
CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
Néron S, Boire G, Dussault N, Racine C, de Brum-Fernandes AJ, Côté S, Jacques A.
Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
Oen K, Tucker L, Huber AM, Miettunen P, Scuccimarri R, Campillo S, Cabral DA, Feldman BM, Tse S, Chédeville G, Spiegel L, Schneider R, Lang B, Ellsworth J, Ramsey S, Dancey P, Silverman E, Chetaille AL, Cameron B, Johnson N, Dorval J, Petty RE, Duffy KW, Boire G, Haddad E, Houghton K, Saint-Cyr C, Turvey SE, Benseler S, Cheang M, Yeung RS, Duffy CM.
The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G.
Akhavan PS, Neville C, Su J, Kassis J, Solymoss S, Pineau C, Peschken C, Pope J, Boire G, Rauch J, Fortin PR. Vascular Events in Systemic Lupus Erythematosus (SLE): Evaluation of Thrombophilic Factors in a Multicentre Inception Cohort (Thrombofil).Poster presentation at the Canadian Rheumatology Association 64th Annual Meeting and Scientific Program, Kananaskis, Alberta, February 18-21, 2009.The Journal of Rheumatology2009;36 (11):2604;doi:10.3899/jrheum.090763.
Bykerk VP, Boire G, Haraoui B, Pope J, Hitchon C, Jamal S, Cheng CK, Thorne C, Mosher D, Ahluwalia V, Larche M, Bensen B, Khraishi M, Zummer M, Nair B, Bell M, Cividino A, Klinkhoff A. Successful Clinical Outcomes in Canadian Early Inflammatory Arthritis Patients: Data from the CATCH Study.Poster presentation at the Canadian Rheumatology Association 64th Annual Meeting and Scientific Program, Kananaskis, Alberta, February 18-21, 2009.The Journal of Rheumatology2009;36 (11):2591;doi:10.3899/jrheum.090763.
Boire G, Beaulieu M, Lambert D, Cabana F. The OPTIMUS intervention: Primary Care Practitioners treating osteoporosis in up to 64% of patients with fragility fracture. J Bone Miner Res 2009;24 (Suppl 1). Available at http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=e1ed0ab6-2df2-4277-a9dd-f45cd94400e4. Accessed September 25, 2009.
Boire G, Cabana F, Mikhail S, Lambert D. Who is Not Ttreated Following the Implementation of OPTIMUS, a Successful Initiative to Treat Osteoporosis Following a Fragility Fracture. JBMR 2010. Accepted as a poster presention at the ASBMR Annual Meeting in Toronto (Canada).
Cabana F, Beaulieu M, Lambert D, Côté PY, Vaillancourt M, Beaulieu MC, Roux S, Boire G. Incidence of subsequent fractures according to age and site of initial non-vertebral fractures: the first 3 years of the OPTIMUS initiative. Accepted as a poster presention at the ASBMR Annual Meeting in San Diego USA. J Bone Miner Res 2011; 26 (Suppl 1). Available at http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=facc29ad-634a-475c-a146-127c1e981a35. Accessed September 10, 2012.
Bykerk VP, Bartlett SJ, Choy E,Boire G, Hitchon C, Pope J, Thorne C, Haraoui B, Keystone E, Bingham CO III, on behalf of OMERACT RA Flare Group and CATCH.
An evaluation of flare in patients with early rheumatoid arthritis using the OMERACT preliminary flare questionnaire.
AprilPM, Roux S, Beaulieu MC, Beaulieu M, Cabana F, Boire G. Estimated FRAX® 10-year fracture risk at the time of incident fracture and upon refracture: results from the OPTIMUS initiative. Accepted as a Plenary Poster Presentation. ASBMR Annual meeting, Minneapolis MN, October 12 2012.
Masetto A, Fernandes AJ, Liang P, Cossette P, Boire G. 2010 ACR/EULAR Rheumatoid Arthritis Classification Criteria Predicts Radiogical, but Not Clinical Outcomes At 18 Months Into Disease in a Canadian Early Arthritis Cohort. Accepted as an Oral Concurrent Session at the 2012 ACR/ARHP Annual Meeting, to be held in Washington, D.C., November 9-14, 2012.
Wong LE, Xiong J, Boire G, Haraoui B, Pope JE, Thorne JC, Hitchon CA, Tin D, Keystone EC, Bykerk VP, CATCH Investigators.
Effect of Duration in Menopause on Disease Presentation in Early Rheumatoid Arthritis (RA). EULAR 2013.
Discrepancy Between Patient and Physician Global Assessments Over Time in Early Rheumatoid Arthritis. Poster. Canadian Rheumatology Association 2013.
Arnold M, Bykerk V, Boire G, Haraoui B, Hitchon C, Thorne C, Keystone E, Pope J.
Are there differences betgween young and older onset early rheumatoid arthritis (RA) and does this impact outcomes? An analysis from the CATCH cohort. Poster. Canadian Rheumatology Association 2013.
Hazlewood G, Thorne C, Pope J, Boire G, Haraoui B, Hitchon C, Keystone E, Tin D, Bykerk V, CATCH Investigators.
The comparative effectiveness of oral methotrexate versus subcutaneous methotrexate for the initial treatment of early rheumatoid arthritis. Poster. EULAR 2013.
Kuriya B, Xiong J, Boire G, Haraoui B, Hitchon C, Pope J, Thorne C, Keystone E, Tin D, Bykerk V.
Predictors of sustained clinical remission in early rheumatoid arthritis-results from the CATCH cohort. Poster. Canadian Rheumatology Association 2013.
Bartlett SJ, Bingham CO, Choy E, Xiong J, Boire G, Haraoui B, Pope JE, Thorne JC, Hitchon CA, Tin D, Keystone EC, Bykerk VP, CATCH Investigators, OMERACT RA Flare Groupe.
Establishing the content validity of OMERACT preliminary flare questions (PFQ) for detecting and measuring disease exacerbations in rheumatoid arthritis. Poster. EULAR 2013.
Hazleweed G, Thorne C, Pope J, Boire G, Haraoui B, Hitchon C, Keystone E, Tin D, CATCH Investigators, Bykerk V.
The comparative effectiveness of oral methotrexate versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis. Poster. Canadian Rheumatology Association 2013.
Lauren Wong, Wei-Ti Huang, Juan Xiong, Gilles Boire, Boulos Haraoui, Janet E. Pope, J. Carter Thorne, Carol A. Hitchon, Diane Tin, Edward Keystone and Vivian P. Bykerk.
Effect Of Age At Menopause In Women With Early Rheumatoid Arthritis.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S162, 374.
Karen Visser, Susan J. Bartlett, Clifton O. Bingham III, Ernest Choy, Daming Lin, Juan Xiong, Gilles Boire, Boulos Haraoui, Carol A. Hitchon, Edward Keystone, Janet E. Pope, J. Carter Thorne, Diane Tin and Vivian P. Bykerk.
Changes In Patient-Reported Joint Counts and Composite Indices Can Identify Flare Of Disease Activity In Recent Onset Rheumatoid Arthritis.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S1230, 2869.
Karen Visser, Janet E. Pope, Ernest Choy, Clifton O Bingham III, Susan J. Bartlett, Gilles Boire, Carol A. Hitchon, J. Carter Thorne, Boulos Haraoui, Diane Tin, Edward Keystone and Vivian P.
Reliability and Validity Of Patient-Reported Joint Counts and Determinants Of Disagreement With The Physician In Recent Onset Rheumatoid Arthritis.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S1229, 2868.
Jeffrey R. Curtis, Shuo Yang, Lang Chen, Janet E. Pope, Edward C. Keystone, Boulos Haraoui, Gilles Boire, J. Carter Thorne, Diane Tin, Carol A. Hitchon, Clifton O. Bingham III and Vivian P. Bykerk.
Determining The Absolute Change In The Clinical Disease Activity Index (CDAI) To Define a Minimally Important Difference.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S1228, 2866.
Mohammed Omair, Edward C. Keystone, Juan Xiong, Gilles Boire, Janet E. Pope, J. Carter Thorne, Carol A. Hitchon, Boulos Haraoui, Diane Tin, Deborah Weber, Vivian P. Bykerk and Pooneh Akhavan.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S978, 2296.
Grace Yang, Vivian P. Bykerk, J. Carter Thorne, Gilles Boire, Diane Tin, Carol A. Hitchon, Edward Keystone, Boulos Haraoui and Janet E. Pope.
Does Socioeconomic Status Affect Outcomes In Early Rheumatoid Arthritis? Data From An Inception Cohort.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S969, 2276.
Vivian P. Bykerk, Karen Visser, Ernest Choy, Clifton O. Bingham III, Daming Lin, Juan Xiong, Gilles Boire, Boulos Haraoui, Carol A. Hitchon, Janet E. Pope, J. Carter Thorne, Diane Tin, Edward C. Keystone, Susan J. Bartlett, - CATCH Investigators and - OMERACT Flare Working Group.
Responsiveness Of The Outcomes Measures In Rheumatology Clinical Trials Initiative’s Preliminary Flare Questions To Detect Flares Within Patients In The Canadian Early Arthritis Cohort.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S968, 2275.
Susan J. Bartlett, Clifton O. Bingham III, Ernest Choy, Juan Xiong, Gilles Boire, Boulos Haraoui, Janet E. Pope, J. Carter Thorne, Carol A. Hitchon, Diane Tin, Edward C. Keystone and Vivian P. Bykerk.
Assessing Significant Flares In Rheumatoid Arthritis: Validity Of The Outcome Measures In Rheumatology Preliminary Flare Questions In The Canadian Early Arthritis Cohort.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S953, 2241.
Pooneh Akhavan, Bindee Kuriya, Edward C. Keystone, Juan Xiong, Janet E. Pope, Gilles Boire, Diane Tin, Boulos Haraoui, Carol A. Hitchon and Vivian P. Bykerk.
Reaching The Target Of Low Disease Activity At 6 Months Predicts Better Long-Term Functional Outcome In Patients With Early Rheumatoid Arthritis.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S762, 1791.
Walter P. Maksymowych, Dirkjan van Schaardenburg, Desire van der Heijde, Robert Landewe, Gilles Boire, Maarten Boers, Vivian P. Bykerk, Edward C. Keystone, Katherine A. Siminovitch, Mairead Murphy and Anthony Marotta.
91% Of Early RA Patients Are Positive For Serum 14–3–3_ Or Its Auto-Antibodies.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S760, 1786.
Sonia Jean, Philippe Gamache, Marie Hudson, Louis Bessette, Paul R. Fortin, Gilles Boire and Sasha Bernatsky.
Trends In Incidence and Mortality In Rheumatoid Arthritis and Systemic Autoimmune Rheumatic Diseases In Quebec, Canada: A Population-Based Study.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S746, 1756.
Glen S. Hazlewood, J. Carter Thorne, Janet E. Pope, Juan Xiong, Gilles Boire, Boulos Haraoui, Carol A. Hitchon, Edward C. Keystone, Diane Tin and Vivian P. Bykerk.
Subcutaneous Delivery Of Methotrexate Is Associated With Improved Treatment Survival Compared To Oral Administration For The Initial Treatment Of Patients With Early Rheumatoid Arthritis.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S627, 1475.
Jonathan D. Jones, B. JoNell Hamilton, Greg Challener, Artur Fernandes, Pierre Cossette, Patrick Liang, Ariel Masetto, HA Menard, Nathalie Carrier, Gilles Boire and William Rigby.
CXCL13 Is Elevated In Early and In Established Seropositive Rheumatoid Arthritis and Correlates With Rheumatoid Factor Levels.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S589, 1395.
Michael Arnold, Vivian P. Bykerk, Gilles Boire, Boulos Haraoui, Carol A. Hitchon, J. Carter Thorne, Edward Keystone and Janet E. Pope.
Are There Differences Between Young and Older Onset Early Rheumatoid Arthritis and Does This Impact Outcomes? An Analysis From The Canadian Early Arthritis Cohort.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S567, 1343.
Tommy Choy, Vivian P. Bykerk, Gilles Boire, Boulos Haraoui, Carol A. Hitchon, J. Carter Thorne, Edward . Keystone and Janet E. Pope.
Physician Global Assessment At Three Months Is Strongly Predictive Of Remission At 12 Months In Early Rheumatoid Arthritis. Results From The Canadian Early Arthritis Cohort.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S562, 1329.
Mihaela Popescu, Edith Villeneuve, Boulos Haraoui, Gilles Boire, Carol A. Hitchon, Edward C. Keystone, Janet E. Pope, J. Carter Thorne, Diane Tin and Vivian P. Bykerk.
Prevalence and Impact Of Soft Tissue Manifestations In Early Inflammatory Arthritis: Results From The Canadian Early Arthritis Cohort.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S557, 1318.
Lillian J. Barra, Janet E. Pope, Boulos Haraoui, Carol A. Hitchon, J. Carter Thorne, Edward C. Keystone, Diane Tin, Gilles Boire and Vivian P. Bykerk.
Prognosis Of Seronegative Patients In a Large Prospective Cohort Of Patients With Early Inflammatory Arthritis.
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S553, 1309.
Bindee Kuriya, Juan Xiong, Gilles Boire, Boulos Haraoui, Carol A. Hitchon, Janet E. Pope, J. Carter Thorne, Diane Tin, Edward C. Keystone, Cheryl Barnabe, Pooneh Akhavan and Vivian P. Bykerk.
Do Sustained Clinical Remission and Sustained Low Disease Activity Equally Predict Functional Status In Early Rheumatoid Arthritis?
ACR Meeting, October 25-30, 2013 – San Diego, California. Arthritis & Rheumatism 65;S10:S552, 1306.
Deborah M. Levy, Shirley ML Tse, Elizabeth Stringer, Jaime Guzman, Roberta A. Berard, Karen Watanabe Duffy, Dax Rumsey, Mercedes O. Chan, Rosie Scuccimarri, Adam M. Huber, Lori B. Tucker, Rae SM Yeung, Ciaran M. Duffy, Kiem Oen and The ReACCh Out Investigators (Gilles Boire).
The Research In Arthritis In Canadian Children Emphasizing Outcomes (ReACCh Out) Cohort: Are We Achieving Clinically Important Outcomes?
Arthritis & Rheumatism 65;S10:S1194, 2790.
M. Omair, P. Akhavan, E. C. Keystone, J. Xiong, G. Boire, J. E. Pope, J. C. Thorne, C. A. Hitchon, B. Haraoui, D. Tin, D. A. Weber, V. P. Bykerk, CATCH Investigators.
Relationship Between DAS28 1.2 and SDAI50 Responses in Rheumatology Arthritis.
M. Arnold, V. P. Bykerk, B. P. Haraoui, G. Boire, C. Hitchon, C. Thorne, E. Keystone, J. E. Pope.
T. Choy, V. P. Bykerk, B. P. Haraoui, G. Boire, C. Hitchon, C. Thorne, E. Keystone, J. E. Pope.
Physician Global Assessment at three months is strongly Predicitve of Disease Activity at 12 Months in Early Rheumatoid Arthritis. Results from the CATCH Cohort.
S. J. Bartlett, C. O. Bingham, E. Choy, J. Xiong, G. Boire, B. Haraoui, J. E. Pope, J. C. Thorne, C. A. Hitchon, D. Tin, E. C. Keystone, V. P. Bykerk, CATCH Investigators and OMERACT RA Flare Group.
L. E. Wong, J. Xiong, G. Boire, B. Haraoui, J. E. Pope, J. C. Thorne, C. A. Hitchon, D. Tin, E. C. Keystone, V. P. Bykerk on behalf of CATCH Investigators.
Effect of duration in menopause on disease presentation.
V. P. Bykerk, J. E. Pope, J. Xiong, G. Boire, B. Haraoui, J. C. Thorne, C. A. Hitchon, D. Tin, E. C. Keystone, on behalf of CATCH investigators.
Comparison of DAS28 using ESR and CRP in an Early Rheumatoid Arthritis Cohort.
G. Hazlewood, C. Thorne, J. Pope, G. Boire, B. Haraoui, C. Hitchon, E. Keystone, D. Tin, V. Bykerk, CATCH Investigators.
The comparative effectiveness of oral methotrexate. EULAR June 12-15, 2013 – Madrid, Spain.
P.-M. April, F. Cabana, M.-C. Beaulieu, M. Beaulieu, S. Roux, G. Boire.
Up to half of first fragility fractures (FF), and a third of recurrent FF, occur in patients with low or moderate estimated Frax® 10-year fracture risk: results from the optimus initiative.
EULAR June 12-15, 2013 – Madrid, Spain. Ann Rheum Dis 2013; 72(Suppl 3):294.
Masetto A, Fernandes A, Liang P, Cossette P,Boire G.
2010 ACR/EULAR Rheumatoid Arthritis Classification Criteria Predicts Radiogical, but Not Clinical Outcomes at 18 Months into Disease in a Canadian Early Arthritis Cohort.
CRA Annual Scientific Meeting, February 13-16, 2013, Ottawa, Ontario.
Bernatsky S, Dekis A, Boire G, Bessette L, Fortin P, Hudson M, Pineau C, Clarke A, Jean S, Chetaille AL, Ehrmann Feldman D, Belisle P, Bergeron L, Joseph L.
Glen Hazlewood ( Calgary); Carter Thorne (Southlake Regional Health Care, The Arthritis Program, Newmarket); Janet Pope (University of Western Ontario, London); Gilles Boire (Université de Sherbrooke, Sherbrooke); Boulos Haraoui (University of Montreal, Montreal); Carol Hitchon (University of Manitoba, Winnipeg); Edward Keystone (University of Toronto, Toronto); Diane Tin (Southlake Regional Health Centre, Newmarket); all CATCH investigators (U of T, Toronto); Vivian Bykerk (Mount Sinai Hospital, Toronto).
The Comparative Effectiveness of Oral Methotrexate versus Subcutaneous Methotrexate for the Treatment of Early Rheumatoid Arthritis.
CRA Annual Scientific Meeting, February 13-16, 2013, Ottawa, Ontario. J Rheumatol 40(6):P971, POS45.
Tommy Choy (London); Vivian Bykerk (Mount Sinai Hospital, Toronto); Gilles Boire (Université de Sherbrooke, Sherbrooke); Boulos Haraoui (University of Montreal, Montreal); Carol Hitchon (University of Manitoba, Winnipeg); Carter Thorne (Southlake Regional Health Care, The Arthritis Program, Newmarket); Edward Keystone (University of Toronto, Toronto); Janet Pope (University of Western Ontario, London).
Physician Global Assessment at Three Months is Strongly Predictive of Disease Activity at 12 Months in Early Rheumatoid Arthritis. Results from the CATCH Cohort.
CRA Annual Scientific Meeting, February 13-16, 2013, Ottawa, Ontario. J Rheumatol 40(6):972, POS51.
Bindee Kuriya (University of Toronto, Toronto); Juan Xiong (The Rebecca MacDonald Center for Arthritis and Autoimmunity, Toronto); Gilles Boire (Université de Sherbrooke, Sherbrooke); Boulos Haraoui (University of Montreal, Montreal); Carol Hitchon (University of Manitoba, Winnipeg); Janet Pope (University of Western Ontario, London); Carter Thorne (Southlake Regional Health Care, The Arthritis Program, Newmarket); Edward Keystone (University of Toronto, Toronto); Diane Tin (Southlake Regional Health Centre, Newmarket); Vivian Bykerk (Mount Sinai Hospital, Toronto).
Predictors of Sustained Clincial Remission in Early Rheumatoid Arthritis- Results from the CATCH Cohort.
CRA Annual Scientific Meeting, February 13-16, 2013, Ottawa, Ontario. J Rheumatol 40(6):987, POS94.
Carol Hitchon (University of Manitoba, Winnipeg); Gilles Boire (Université de Sherbrooke, Sherbrooke); Boulos Haraoui (University of Montreal, Montreal); Edward Keystone (University of Toronto, Toronto); Janet Pope (University of Western Ontario, London); Carter Thorne (Southlake Regional Health Care, The Arthritis Program, Newmarket); Vivian Bykerk (Mount Sinai Hospital, Toronto); all CATCH investigators (U of T, Toronto).
Self Reported Comorbidity is Common in Early Inflammatory Arthritis and Associated with Poorer Function and Quality of Life and Greater Disease Activity: Results from the Canadian Early Arthritis Cohort.
CRA Annual Scientific Meeting, February 13-16, 2013, Ottawa, Ontario. J Rheumatol 40(6):P998, POS123.
Michael Arnold (London); Vivian Bykerk (Mount Sinai Hospital, Toronto); Gilles Boire (Université de Sherbrooke, Sherbrooke); Boulos Haraoui (University of Montreal, Montreal); Carol Hitchon (University of Manitoba, Winnipeg); Carter Thorne (Southlake Regional Health Care, The Arthritis Program, Newmarket); Edward Keystone (University of Toronto, Toronto); Janet Pope (University of Western Ontario, London).
Are there Differences between Young and Older Onset Early Rheumatoid Arthritis (RA) and does this Impact Outcomes? An Analysis from the CATCH Cohort.
CRA Annual Scientific Meeting, February 13-16, 2013, Ottawa, Ontario. J Rheumatol 40(6):P1004, POS140.
Pierre-Marc April (Universite de Sherbrooke, Sherbrooke); Francois Cabana (Centre hospitalier universitaire de Sherbrooke, Sherbrooke); Sophie Roux (Universite de Sherbrooke, Sherbrooke); Marie-Claude Beaulieu (Universite de Sherbrooke, Sherbrooke); Michele Beaulieu (Merck Frosst Canada, Kirkland); Gilles Boire (Universite de Sherbrooke, Sherbrooke).
Limitations of Estimated FRAX® 10-Year Fracture Risk at the Time of Incident Fracture and Upon Refracture: Results from the OPTIMUS Initiative.
CRA Annual Scientific Meeting, February 13-16, 2013, Ottawa, Ontario. J Rheumatol 40(6):P1009, POS155.
Pooneh Akhavan (Mount Sinai Hospital, University of Toronto, Toronto); Vivian Bykerk (Mount Sinai Hospital, Toronto); Juan Xiong (The Rebecca MacDonald Center for Arthritis and Autoimmunity, Toronto); Carter Thorne (Southlake Regional Health Care, The Arthritis Program, Newmarket); Janet Pope (University of Western Ontario, London); Gilles Boire (Université de Sherbrooke, Sherbrooke); Carol Hitchon (University of Manitoba, Winnipeg); Edward Keystone (University of Toronto, Toronto); all CATCH investigators (U of T, Toronto).
Discrepancy Between Patient and Physician Global Assessments Over Time in Early Rheumatoid Arthritis.
Susan Bartlett (McGill University, Montreal); Clifton Bingham (John Hopkins University, Baltimore); Juan Xiong (The Rebecca MacDonald Center for Arthritis and Autoimmunity, Toronto); Ernest Choy (King's College Hospital, London); Gilles Boire (Université de Sherbrooke, Sherbrooke); Carol Hitchon (University of Manitoba, Winnipeg); Janet Pope (University of Western Ontario, London); Carter Thorne (Southlake Regional Health Care, The Arthritis Program, Newmarket); Diane Tin (Southlake Regional Health Centre, Newmarket); Boulos Haraoui (University of Montreal, Montreal); Edward Keystone (University of Toronto, Toronto); Vivian Bykerk (Mount Sinai Hospital, Toronto).
Self Management Strategies of Rheumatoid Arthritis Patients Experiencing a disease Flare.
CRA Annual Scientific Meeting, February 13-16, 2013, Ottawa, Ontario. J Rheumatol 40(6):P1017, POS177.

References: V.

 V.

 V. 
 V. 
 V. 
 V. 
 V. 

V. 
 V.